HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiviral activity of trichothecene mycotoxins (deoxynivalenol, fusarenon-X, and nivalenol) against herpes simplex virus types 1 and 2.

Abstract
The effect of trichothecene mycotoxins, deoxynivalenol (DON), fusarenon-X (FX) and nivalenol (NIV), on plaque formation of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) in HEp-2 cells was examined. The 50% effective concentrations (EC50) of DON, FX, and NIV for HSV-1 plaque formation were 160, 56, and 120 ng/ml, respectively. Those for HSV-2 plaque formation were 94, 26, and 50 ng/ml, respectively. These three mycotoxins showed about 2-fold higher selectivity to HSV-2 than to HSV-1. Plaque formation of HSV-1 was not inhibited with trichothecenes at concentrations completely inhibiting plaque formation when cells were treated during virus adsorption period or 15 hr before infection. These results indicate that trichothecenes affect replication of HSV-1 after virus adsorption, but not before or during virus adsorption to the host cells.
AuthorsN Tani, Y Dohi, Y Onji, K Yonemasu
JournalMicrobiology and immunology (Microbiol Immunol) Vol. 39 Issue 8 Pg. 635-7 ( 1995) ISSN: 0385-5600 [Print] Australia
PMID7494505 (Publication Type: Journal Article)
Chemical References
  • Mycotoxins
  • Trichothecenes
  • fusarenon-X
  • nivalenol
  • deoxynivalenol
Topics
  • Cell Line
  • Herpesvirus 1, Human (drug effects)
  • Herpesvirus 2, Human (drug effects)
  • Humans
  • Mycotoxins (pharmacology)
  • Trichothecenes (pharmacology)
  • Viral Plaque Assay
  • Virus Replication (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: